Resource utilization and productivity loss in persons with spina bifida − an observational study of patients in a tertiary urology clinic in <scp>G</scp>ermany

Nooten, F.E. van; Winnette, Randall; Stein, Raimund; Kissner, Marion; Schröder, Annette; Jöckel, M.; Raluy-Callado, Mireia; Lambrelli, Dimitra; Meinhardt, M.; Wasiak, Radoslaw

doi:10.1111/ene.12524

Cited by 4 publications

(2 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For comparison, a German study evaluating hospital resource utilization within the spina bifida population reported an annual average of 14.8 hospital days per patient for hydrocephalus and non-hydrocephalus-related management. 27 Differences between HCRN centers regarding surgical outcomes were acknowledged and controlled for by study team members through statistical methods. Analysis of the variation in surgical outcomes between HCRN centers revealed that HCRN site had a statistically significant impact on the number of surgical revisions and hospital admission days due to revision at 1-, 3-, and 5-year outcomes.…”

Section: Discussionmentioning

confidence: 99%

Surgical resource utilization after initial treatment of infant hydrocephalus: comparing ETV, early experience of ETV with choroid plexus cauterization, and shunt insertion in the Hydrocephalus Clinical Research Network

Pindrik

Riva-Cambrin

Kulkarni

et al. 2020

Journal of Neurosurgery: Pediatrics

View full text Add to dashboard Cite

OBJECTIVEFew studies have addressed surgical resource utilization—surgical revisions and associated hospital admission days—following shunt insertion or endoscopic third ventriculostomy (ETV) with or without choroid plexus cauterization (CPC) for CSF diversion in hydrocephalus. Study members of the Hydrocephalus Clinical Research Network (HCRN) investigated differences in surgical resource utilization between CSF diversion strategies in hydrocephalus in infants.METHODSPatients up to corrected age 24 months undergoing initial definitive treatment of hydrocephalus were reviewed from the prospectively maintained HCRN Core Data Project (Hydrocephalus Registry). Postoperative courses (at 1, 3, and 5 years) were studied for hydrocephalus-related surgeries (primary outcome) and hospital admission days related to surgical revision (secondary outcome). Data were summarized using descriptive statistics and compared using negative binomial regression, controlling for age, hydrocephalus etiology, and HCRN center. The study population was organized into 3 groups (ETV alone, ETV with CPC, and CSF shunt insertion) during the 1st postoperative year and 2 groups (ETV alone and CSF shunt insertion) during subsequent years due to limited long-term follow-up data.RESULTSAmong 1090 patients, the majority underwent CSF shunt insertion (CSF shunt, 83.5%; ETV with CPC, 10.0%; and ETV alone, 6.5%). Patients undergoing ETV with CPC had a higher mean number of revision surgeries (1.2 ± 1.6) than those undergoing ETV alone (0.6 ± 0.8) or CSF shunt insertion (0.7 ± 1.3) over the 1st year after surgery (p = 0.005). At long-term follow-up, patients undergoing ETV alone experienced a nonsignificant lower mean number of revision surgeries (0.7 ± 0.9 at 3 years and 0.8 ± 1.3 at 5 years) than those undergoing CSF shunt insertion (1.1 ± 1.9 at 3 years and 1.4 ± 2.6 at 5 years) and exhibited a lower mean number of hospital admission days related to revision surgery (3.8 ± 10.3 vs 9.9 ± 27.0, p = 0.042).CONCLUSIONSAmong initial treatment strategies for hydrocephalus, ETV with CPC yielded a higher surgical revision rate within 1 year after surgery. Patients undergoing ETV alone exhibited a nonsignificant lower mean number of surgical revisions than CSF shunt insertion at 3 and 5 years postoperatively. Additionally, the ETV-alone cohort demonstrated significantly fewer hospital admission days related to surgical management of hydrocephalus within 3 years after surgery. These findings suggest a time-dependent benefit of ETV over CSF shunt insertion regarding surgical resource utilization.

show abstract

Section: Discussionmentioning

confidence: 99%

Surgical resource utilization after initial treatment of infant hydrocephalus: comparing ETV, early experience of ETV with choroid plexus cauterization, and shunt insertion in the Hydrocephalus Clinical Research Network

Pindrik

Riva-Cambrin

Kulkarni

et al. 2020

Journal of Neurosurgery: Pediatrics

View full text Add to dashboard Cite

show abstract

“…Advances in neurology occur across a broad front including neuro‐oncology, trauma, neuro‐otology and neurodevelopment. These areas also overlap with other specialist areas within the neurosciences.…”

mentioning

confidence: 99%

Advances in neurological research and practice

Schapira¹

2016

Euro J of Neurology

View full text Add to dashboard Cite

Cost comparison of intra-detrusor injection of botulinum toxin versus augmentation cystoplasty for refractory neurogenic detrusor overactivity in children

Kim

Nang

RoyChoudhury

et al. 2022

Journal of Pediatric Urology

View full text Add to dashboard Cite

Resource utilization and productivity loss in persons with spina bifida − an observational study of patients in a tertiary urology clinic in Germany

Abstract: The results indicate that persons with SB require a substantial amount of interaction with healthcare providers, as well as other healthcare-related resource use, both in the shorter and longer terms.

Cited by 4 publications

References 11 publications

Surgical resource utilization after initial treatment of infant hydrocephalus: comparing ETV, early experience of ETV with choroid plexus cauterization, and shunt insertion in the Hydrocephalus Clinical Research Network

Surgical resource utilization after initial treatment of infant hydrocephalus: comparing ETV, early experience of ETV with choroid plexus cauterization, and shunt insertion in the Hydrocephalus Clinical Research Network

Advances in neurological research and practice

Cost comparison of intra-detrusor injection of botulinum toxin versus augmentation cystoplasty for refractory neurogenic detrusor overactivity in children

Contact Info

Product

Resources

About